Basket cover image
15 handpicked stocks

New Moon Portfolio

This collection represents the very beginning of the next technological cycle. These carefully selected companies are sowing the seeds of future industries, giving you early exposure to disruptive innovators poised for exponential growth as their technologies reshape our world.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+5

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at जून 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

RKLB

Rocket Lab USA Inc

RKLB

Current price

$40.92

As a leader in small satellite launch services, this company is at the forefront of the new space race and commercial exploration.

PL

Planet Labs PBC

PL

Current price

$6.38

Providing daily satellite imagery of the Earth, this company offers a new perspective on global economic and environmental trends.

SYM

Symbotic Inc

SYM

Current price

$46.80

This company is revolutionizing supply chains with its A.I.-powered robotics platform, representing a new beginning for warehouse automation.

About This Group of Stocks

1

Our Expert Thinking

We've identified companies creating entirely new markets through groundbreaking technologies like AI diagnostics, commercial space exploration, gene editing, and carbon recycling. These pioneers are positioned at the forefront of technological revolutions, with potential to become the defining leaders of tomorrow's industries.

2

What You Need to Know

This collection represents higher-risk, high-growth potential investments intended as a satellite component of a diversified portfolio. Each company possesses pioneering technology and strong intellectual property that could potentially reshape entire sectors before they become household names.

3

Why These Stocks

These companies were carefully selected for their position at the beginning of new technological cycles. They're benefiting from accelerated venture funding and growing public market interest in deep-tech and biotech breakthroughs, which creates powerful momentum for development and adoption.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+261.14%

Group Performance Snapshot

261.14%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 261.14% over the next year.

12 of 15

Stocks Rated Buy by Analysts

12 of 15 assets in this group are rated Buy by professional analysts.

416% vs 4%

Group Growth vs Bank interest

This group averaged a 416% return last month, beating the typical 4% bank rate.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🌱

Moonshot Potential

These companies aren't just growing businesses – they're creating entirely new industries. By getting in early, you could position yourself at the ground floor of technologies that may define the next decade.

🧬

The Innovation Wave Is Here

A dramatic surge in deep-tech and scientific funding is accelerating these breakthroughs from research to reality. This powerful catalyst is compressing development timelines that once took decades into just a few years.

🔭

Before They Become Household Names

Many investors wait until revolutionary companies hit the mainstream, but the most significant returns often come earlier. These pioneers have the potential to become the defining leaders of tomorrow's tech landscape.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.